Top Markets
#1 Siren Siren +45.21%
#2 Wrapped NXM Wrapped NXM +12.76%
#3 Cryptopia Cryptopia +9.12%
#4 Mubarak Mubarak +6.70%
#5 Verus Coin Verus Coin +6.66%
#6 Ontology Ontology +6.61%
#7 Helium Helium +6.60%
#8 Axelar Axelar +6.26%
#9 Merlin Chain Merlin Chain +5.91%
#10 Notcoin Notcoin +5.79%
Coin of the day
Siren Siren
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Cybin Inc. Common Stock Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP
Pozycja w akcjach #11956
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Cena akcji
$10.30
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$638.32M
Zmiana (1 dzień)
2.88%
Zmiana (1 rok)
-
Kraj
CA
Handel Cybin Inc. Common Stock (HELP)

Kategoria

Healthcare
Historia stopy dywidendy dla Cybin Inc. Common Stock (HELP)
Stopa dywidendy (TTM) dla Cybin Inc. Common Stock (symbol akcji: HELP) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Cybin Inc. Common Stock (HELP) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH